Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor induction of estrus in prepuberal gilts and healthy weaned sows experiencing delayed return to estrus.
LEARN MOREFor the vaccination of healthy 18-day old chicken embryos or chickens 1-day of age against standard and variant infectious bursal disease.
LEARN MORE